Paid Clinical Trials in Salt Lake City, UT
As of September 2026, 955 paid clinical trials are recruiting in Salt Lake City, Utah. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Salt Lake City offers studies at sites including University of Utah for conditions such as Breast Cancer, Acute Myeloid Leukemia, Multiple Myeloma, Advanced Solid Tumor. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Salt Lake City
Trials by drug in Salt Lake City
Filter results
Newly added in Salt Lake City
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Agreement of Two OCT Biometers: A Pilot Study
Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.
Stiffness and Low Dose Irradiation RCT
842 clinical trials
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Top Research Study Locations in Salt Lake City
Researchers run research studies in Salt Lake City, UT at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Utah | Stroke, Traumatic Brain Injury, Acute Myeloid Leukemia | 211 |
| Huntsman Cancer Institute/University of Utah | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 | 70 |
| Primary Children's Hospital | Neuroblastoma, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia | 62 |
| Huntsman Cancer Institute | Multiple Myeloma, Colorectal Cancer, NSCLC | 58 |
| Huntsman Cancer Institute, University of Utah | Advanced Solid Tumor, Breast Cancer, HIV Infection | 34 |
| University of Utah Health | Heart Failure, Interstitial Lung Disease, Hemorrhagic Stroke | 30 |
| University of Utah Hospital | Cardiovascular Diseases, Abdominal Aortic Aneurysm, Cirrhosis | 23 |
| Huntsman Cancer Institute at University of Utah | Gynecologic Cancer, Breast Cancer, Metastatic Castration-resistant Prostate Cancer | 23 |
| VA Salt Lake City Health Care System, Salt Lake City, UT | Aging, Alcohol Use Disorder, Alcohol Use Disorder (AUD) | 19 |
| University of Utah Sugarhouse Health Center | Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | 16 |
| Utah Cancer Specialists | Colorectal Cancer, Multiple Myeloma, NSCLC | 14 |
| Huntsman Cancer Institute at the University of Utah | Multiple Myeloma, Non-Hodgkin Lymphoma, Plasma Cell Leukemia | 14 |
| LDS Hospital | Carbon Monoxide Poisoning, Cardiovascular Diseases, Castration-Sensitive Prostate Carcinoma | 11 |
| The University of Utah | Bowel; Stricture, Cardiovascular Disease and Lipoprotein(a), Cerebral Palsy | 11 |
| University of Utah Huntsman Cancer Institute | Advanced Melanoma, Breast Cancer, ARID1A Gene Mutation | 11 |
| Intermountain Healthcare | Large B-cell Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma | 10 |
| University of Utah Orthopaedic Center | Acetabular Fracture, Chronic Low-back Pain, Chronic Pain | 8 |
| Clinical Trial Site | Acute Hepatic Porphyria, Breast Cancer, ER Positive Breast Cancer | 7 |
| University of Utah - Huntsman Cancer Institute | Advanced Solid Tumor, Bladder Cancer, Breast Cancer | 7 |
| University of Utah Orthopedics | Ankle Injuries, Cervical Myelopathy, Early Mobilization | 7 |
| GSK Investigational Site | HIV Infections, Gastrointestinal Neoplasms, Hypereosinophilic Syndrome | 6 |
| Intermountain Health | Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, Advanced Ovarian Carcinoma | 6 |
| St. Mark's Hospital | Persistent Atrial Fibrillation, AV Block, Atrial Fibrillation | 6 |
| The Eye Institute of Utah | Anterior Segment of Eye, Aphakia, Astigmatism | 6 |
| University of Utah Healthcare | Intracerebral Hemorrhage, Atrial Fibrillation, Basal Ganglia Intracerebral Hemorrhage | 6 |
Active & Upcoming Studies in Salt Lake City (2026)
Recruiting trials in Salt Lake City grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (303 active studies)
- Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial · Phase 2 · National Cancer Institute (NCI)
- Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial) · Phase 2 · National Cancer Institute (NCI)
Neurology & pain (75 active studies)
- Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease · Phase 4 · VA Office of Research and Development
- A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Cardiovascular (66 active studies)
- Gestational Hypertension and Preeclampsia Blood Pressure (BP) Treatment Goals Less Than 140/90 vs. Less Than 160/110 mmHg: The GOALPOST Trial · Phase 3 · The George Washington University Biostatistics Center
- INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery · Abiomed Inc.
Diabetes & metabolic (33 active studies)
- Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema · Phase 3 · Novo Nordisk A/S
- Partnership to Reduce Obesity in Community Health Center Patients (SMARTLife Utah) · University of Utah
Eye & vision (19 active studies)
- Study of Serine Supplementation to Protect Vision in MacTel · Phase 3 · The Lowy Medical Research Institute Limited
- Lesion-tailored, Fundus-controlled Perimetry in Geographic Atrophy (GA). · University of Utah
Pediatric (19 active studies)
- A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction · Phase 3 · Bayer
- A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study · Carelon Research
Mental health & behavior (16 active studies)
- KALM-B: Ketamine-assisted Psychotherapy (KAP) to Lessen Morbidity After Burn Injury · Phase 2 · Irma Fleming
- LLM Intervention for Tobacco in Underserved Populations (LIFT-UP) · University of Utah
Vaccines (9 active studies)
- A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age · Phase 3 · GlaxoSmithKline
- Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above. · Phase 1, Phase 2 · Sanofi
HIV / STI (6 active studies)
- A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed · Phase 3 · ViiV Healthcare
- A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1 · Phase 2 · Gilead Sciences
Common conditions studied in Salt Lake City
- Breast Cancer (21 active studies)
- Acute Myeloid Leukemia (14 active studies)
- Multiple Myeloma (13 active studies)
- Advanced Solid Tumor (12 active studies)
- Heart Failure (11 active studies)
- Ovarian Cancer (10 active studies)
Leading research sponsors in Salt Lake City
- University of Utah
- National Cancer Institute (NCI)
- VA Office of Research and Development
- Novartis Pharmaceuticals
- Children's Oncology Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Salt Lake City?
There are approximately 955 recruiting clinical trials in Salt Lake City, Utah listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Salt Lake City pay participants?
Most recruiting trials in Salt Lake City compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Salt Lake City?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Salt Lake City?
The most common conditions under active study in Salt Lake City include Breast Cancer (21), Acute Myeloid Leukemia (14), Multiple Myeloma (13), Advanced Solid Tumor (12), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Salt Lake City?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Salt Lake City on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Salt Lake City?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Salt Lake City?
Recruiting research sites in Salt Lake City include University of Utah, Huntsman Cancer Institute/University of Utah, Primary Children's Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Salt Lake City right now?
The largest active categories in Salt Lake City are Cancer & tumors (303), Neurology & pain (75), Cardiovascular (66). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.